Cryoport director sells shares, receives equity grants
Cryoport, Inc. director Ramkumar Mandalam reported a mix of equity grants and a stock sale.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Cryoport, Inc. director Ramkumar Mandalam reported a mix of equity grants and a stock sale. On June 5, 2026, he received 10,350 restricted stock rights that vest in full on June 5, 2027 and convert one-for-one into common shares, plus options for 16,077 shares at an exercise price of $15.70 expiring in 2033.
On June 8, 2026, he executed an open-market sale of 23,214 common shares at a weighted average price of $15.4412 per share, in multiple trades between $15.40 and $15.48. Following the sale, he directly holds 67,894 common shares.
Insider Trade Summary
Net Seller: 23,214 shares
Net Sell
3 txns
Insider
Mandalam Ramkumar
Role
Director
Sold
23,214 shs ($358K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 23,214 | $15.4412 | $358K |
| Grant/Award | Option (Right to Buy Common Stock) | 16,077 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 10,350 | $0.00 | $0.00 |
Holdings After Transaction:
Option (Right to Buy Common Stock) — 16,077 contracts (Direct);
Common Stock — 67,894 shares (Direct)
Footnotes (3)
- F1. Reflects grant of restricted stock rights that vest in full on June 5, 2027, and upon vesting automatically convert to shares of common stock on a one-for-one basis.
- F2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.40 to $15.48, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. 1/12th of the options vest on the 5th of the month for twelve months beginning July 5, 2026.
Key Figures
Shares sold: 23,214 shares
Sale price: $15.4412 per share
Post-sale holdings: 67,894 shares
+3 more
6 metrics
Shares sold
23,214 shares
Open-market sale of common stock on June 8, 2026
Sale price
$15.4412 per share
Weighted average sale price, trades between $15.40 and $15.48
Post-sale holdings
67,894 shares
Common stock directly owned after June 8, 2026 sale
Restricted stock rights granted
10,350 units
Grant on June 5, 2026, vesting in full on June 5, 2027
Options granted
16,077 options
Grant on June 5, 2026, right to buy common stock
Option exercise price
$15.70 per share
Exercise price for 16,077 options expiring June 5, 2033
Key Terms
restricted stock rights, weighted average price, options vest
3 terms
restricted stock rights financial
"Reflects grant of restricted stock rights that vest in full on June 5, 2027"
Restricted stock rights are ownership claims in company shares that come with limits on when or how they can be sold or transferred, often tied to time-based or performance conditions. For investors, these rights matter because they affect when insiders truly own or can monetize shares — influencing future share supply, executive incentives, and potential stock price pressure much like a savings account that only becomes withdrawable after meeting set conditions.
weighted average price financial
"The price reported is a weighted average price. These shares were sold in multiple transactions"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
options vest financial
"1/12th of the options vest on the 5th of the month for twelve months"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Cryoport (CYRX) director Ramkumar Mandalam report?
He reported equity grants and a stock sale. On June 5, 2026, he received restricted stock rights and stock options, then on June 8, 2026, he sold 23,214 common shares in open-market transactions at a weighted average price of $15.4412 per share.
What stock awards did Ramkumar Mandalam receive from Cryoport (CYRX) on June 5, 2026?
He received 10,350 restricted stock rights and 16,077 stock options. The restricted stock rights vest in full on June 5, 2027, converting one-for-one into common shares, while the options have a $15.70 exercise price and vest monthly beginning July 5, 2026.
When do Ramkumar Mandalam’s restricted stock rights in Cryoport (CYRX) vest?
They vest in full on June 5, 2027. Once vested, these 10,350 restricted stock rights automatically convert into 10,350 shares of Cryoport common stock on a one-for-one basis, as described in the Form 4 footnote disclosure for the equity grant.
What are the terms of Ramkumar Mandalam’s Cryoport (CYRX) stock options granted in June 2026?
He was granted options for 16,077 shares at a $15.70 exercise price. One-twelfth of the options vest on the fifth of each month for twelve months starting July 5, 2026, and the options expire on June 5, 2033, if not exercised earlier.
AI-generated analysis. How Rhea-AI works. Not financial advice.
